Last updated: August 13, 2022
Sponsor: Mansoura University
Overall Status: Active - Recruiting
Phase
2
Condition
Dysmenorrhea (Painful Periods)
Treatment
N/AClinical Study ID
NCT05299047
R.22.01.1598
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients more than 18 years old of both genders with cancer-related pelvic pain,
- poor pain control or severe side effects with opioid therapy,
- ≥ 4 on a numeric rating scale (NRS) of pain that ranged from 0 (no pain) to 10 (extreme pain).,
- American society of Anesthesiology Physical Status class I and II,
- positive diagnostic block day before the procedure by injecting a local anesthetic (0.25% bupivacaine 10 ml)
- Body mass index ˂ 30 were included in this study.
Exclusion
Exclusion Criteria:
- patient refusal,
- local or systemic sepsis,
- coagulopathy,
- unstable cardiovascular and respiratory diseases,
- previous neurological deficits,
- history of psychiatric disorders,
- history of drug abuse,
- distorted local anatomy,
- those who were allergic to the used medications were excluded from the study.
Study Design
Total Participants: 96
Study Start date:
January 01, 2022
Estimated Completion Date:
September 01, 2022
Study Description
Connect with a study center
Yahya Wahba
Mansoura,
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.